Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bruner

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Cancer Research|June 5, 2001
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlationsT Shono, P J Tofilon, J M Bruner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1990
Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinomaM L Rutledge, S S Robey-Cafferty, E G Silva, et al.
The Journal of Laryngology and Otology|June 1, 1986
S-100 protein and myoepithelial neoplasmsJ G Batsakis, N G Ordonez, J Ro, et al.
Neurosurgery|August 1, 1994
Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiformeA M Ritter, R Sawaya, K R Hess, et al.
Molecular Carcinogenesis|January 1, 1996
Correlation of p53 immunoreactivity and sequencing in patients with gliomaA P Kyritsis, R Xu, M L Bondy, et al.
Journal of Neuroimmunology|March 1, 1995
Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissueM C Gingras, E Roussel, J M Bruner, et al.
Annals of Neurology|May 1, 1993
Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumorsT J Janus, E E Kim, R Tilbury, et al.
The Journal of Pediatrics|September 1, 1988
Salvage chemotherapy for recurrent primary brain tumors in childrenJ van Eys, T Z Baram, A Cangir, et al.
Clinical and Experimental Immunology|August 1, 1996
Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomasE Roussel, M C Gingras, E A Grimm, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 16, 2005
TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activationV K Puduvalli, D Sampath, J M Bruner, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Cancer Research|June 5, 2001
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlationsT Shono, P J Tofilon, J M Bruner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1990
Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinomaM L Rutledge, S S Robey-Cafferty, E G Silva, et al.
The Journal of Laryngology and Otology|June 1, 1986
S-100 protein and myoepithelial neoplasmsJ G Batsakis, N G Ordonez, J Ro, et al.
Neurosurgery|August 1, 1994
Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiformeA M Ritter, R Sawaya, K R Hess, et al.
Molecular Carcinogenesis|January 1, 1996
Correlation of p53 immunoreactivity and sequencing in patients with gliomaA P Kyritsis, R Xu, M L Bondy, et al.
Journal of Neuroimmunology|March 1, 1995
Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissueM C Gingras, E Roussel, J M Bruner, et al.
Annals of Neurology|May 1, 1993
Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumorsT J Janus, E E Kim, R Tilbury, et al.
The Journal of Pediatrics|September 1, 1988
Salvage chemotherapy for recurrent primary brain tumors in childrenJ van Eys, T Z Baram, A Cangir, et al.
Clinical and Experimental Immunology|August 1, 1996
Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomasE Roussel, M C Gingras, E A Grimm, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 16, 2005
TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activationV K Puduvalli, D Sampath, J M Bruner, et al.
Pageof 15